Global and China Methylphenidate Drug Market Insights, Forecast to 2026

List of Tables
Table 1. Methylphenidate Drug Market Segments
Table 2. Ranking of Global Top Methylphenidate Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Methylphenidate Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Tablet
Table 5. Major Manufacturers of Capsule
Table 6. Global Methylphenidate Drug Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Methylphenidate Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Methylphenidate Drug Sales by Regions 2015-2020 (K Units)
Table 9. Global Methylphenidate Drug Sales Market Share by Regions (2015-2020)
Table 10. Global Methylphenidate Drug Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Methylphenidate Drug Sales Forecast by Region (2021-2026) (K Units)
Table 12. Global Methylphenidate Drug Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Methylphenidate Drug Sales Share by Manufacturers (2015-2020)
Table 14. Global Methylphenidate Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Methylphenidate Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Methylphenidate Drug as of 2019)
Table 16. Methylphenidate Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Methylphenidate Drug Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Methylphenidate Drug Price (2015-2020) (USD/Unit)
Table 19. Methylphenidate Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Methylphenidate Drug Product Type
Table 21. Date of International Manufacturers Enter into Methylphenidate Drug Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Methylphenidate Drug Sales by Type (2015-2020) (K Units)
Table 24. Global Methylphenidate Drug Sales Share by Type (2015-2020)
Table 25. Global Methylphenidate Drug Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Methylphenidate Drug Revenue Share by Type (2015-2020)
Table 27. Methylphenidate Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Methylphenidate Drug Sales Share by Type (2021-2026)
Table 29. Global Methylphenidate Drug Sales by Application (2015-2020) (K Units)
Table 30. Global Methylphenidate Drug Sales Share by Application (2015-2020)
Table 31. Global Methylphenidate Drug Sales Share by Application (2021-2026)
Table 32. Global Methylphenidate Drug Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Methylphenidate Drug Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Methylphenidate Drug Revenue Market Share Forecast by Application (2021-2026)
Table 35. China Methylphenidate Drug Sales (K Units) of Key Companies (2015-2020)
Table 36. China Methylphenidate Drug Sales Share by Company (2015-2020)
Table 37. China Methylphenidate Drug Revenue (US$ Million) by Company (2015-2020)
Table 38. China Methylphenidate Drug Sales (K Units) by Type (2015-2020)
Table 39. China Methylphenidate Drug Sales Share by Type (2015-2020)
Table 40. China Methylphenidate Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. China Methylphenidate Drug Price (K Units) by Type (2015-2020)
Table 42. China Methylphenidate Drug Sales (K Units) by Type (2021-2026)
Table 43. China Methylphenidate Drug Sales Share by Type (2021-2026)
Table 44. China Methylphenidate Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. China Methylphenidate Drug Revenue Share by Type (2021-2026)
Table 46. China Methylphenidate Drug Price (K Units) by Type (2021-2026)
Table 47. China Methylphenidate Drug Sales (K Units) by Application (2015-2020)
Table 48. China Methylphenidate Drug Sales Share by Application (2015-2020)
Table 49. China Methylphenidate Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. China Methylphenidate Drug Sales (K Units) by Application (2021-2026)
Table 51. China Methylphenidate Drug Sales Share by Application (2021-2026)
Table 52. China Methylphenidate Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. China Methylphenidate Drug Revenue Share by Application (2021-2026)
Table 54. North America Methylphenidate Drug Sales by Country (2015-2020) (K Units)
Table 55. North America Methylphenidate Drug Sales Market Share by Country (2015-2020)
Table 56. North America Methylphenidate Drug Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Methylphenidate Drug Revenue Market Share by Country (2015-2020)
Table 58. Europe Methylphenidate Drug Sales by Country (2015-2020) (K Units)
Table 59. Europe Methylphenidate Drug Sales Market Share by Country (2015-2020)
Table 60. Europe Methylphenidate Drug Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Methylphenidate Drug Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Methylphenidate Drug Sales by Region (2015-2020) (K Units)
Table 63. Asia Pacific Methylphenidate Drug Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Methylphenidate Drug Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Methylphenidate Drug Revenue Market Share by Region (2015-2020)
Table 66. Latin America Methylphenidate Drug Sales by Country (2015-2020) (K Units)
Table 67. Latin America Methylphenidate Drug Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Methylphenidate Drug Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Methylphenidate Drug Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Methylphenidate Drug Sales by Country (2015-2020) (K Units)
Table 71. Middle East and Africa Methylphenidate Drug Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Methylphenidate Drug Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Methylphenidate Drug Revenue Market Share by Country (2015-2020)
Table 74. Janssen Pharmaceuticals Corporation Information
Table 75. Janssen Pharmaceuticals Description and Business Overview
Table 76. Janssen Pharmaceuticals Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Janssen Pharmaceuticals Methylphenidate Drug Product
Table 78. Janssen Pharmaceuticals Recent Development
Table 79. NEOS Therapeutics Corporation Information
Table 80. NEOS Therapeutics Description and Business Overview
Table 81. NEOS Therapeutics Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. NEOS Therapeutics Product
Table 83. NEOS Therapeutics Recent Development
Table 84. Rhodes Pharmaceuticals Corporation Information
Table 85. Rhodes Pharmaceuticals Description and Business Overview
Table 86. Rhodes Pharmaceuticals Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Rhodes Pharmaceuticals Product
Table 88. Rhodes Pharmaceuticals Recent Development
Table 89. Noven Therapeutics Corporation Information
Table 90. Noven Therapeutics Description and Business Overview
Table 91. Noven Therapeutics Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Noven Therapeutics Product
Table 93. Noven Therapeutics Recent Development
Table 94. Ironshore Pharmaceuticals Corporation Information
Table 95. Ironshore Pharmaceuticals Description and Business Overview
Table 96. Ironshore Pharmaceuticals Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Ironshore Pharmaceuticals Product
Table 98. Ironshore Pharmaceuticals Recent Development
Table 99. Lannett Company Corporation Information
Table 100. Lannett Company Description and Business Overview
Table 101. Lannett Company Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Lannett Company Product
Table 103. Lannett Company Recent Development
Table 104. Novartis Corporation Information
Table 105. Novartis Description and Business Overview
Table 106. Novartis Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Novartis Product
Table 108. Novartis Recent Development
Table 109. Teva Corporation Information
Table 110. Teva Description and Business Overview
Table 111. Teva Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Teva Product
Table 113. Teva Recent Development
Table 114. Tris Pharma Corporation Information
Table 115. Tris Pharma Description and Business Overview
Table 116. Tris Pharma Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Tris Pharma Product
Table 118. Tris Pharma Recent Development
Table 119. Amneal Corporation Information
Table 120. Amneal Description and Business Overview
Table 121. Amneal Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Amneal Product
Table 123. Amneal Recent Development
Table 124. Impax Laboratories Corporation Information
Table 125. Impax Laboratories Description and Business Overview
Table 126. Impax Laboratories Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Impax Laboratories Product
Table 128. Impax Laboratories Recent Development
Table 129. Mylan Corporation Information
Table 130. Mylan Description and Business Overview
Table 131. Mylan Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Mylan Product
Table 133. Mylan Recent Development
Table 134. Trigen Laboratories Corporation Information
Table 135. Trigen Laboratories Description and Business Overview
Table 136. Trigen Laboratories Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Trigen Laboratories Product
Table 138. Trigen Laboratories Recent Development
Table 139. Sun Pharmaceutical Corporation Information
Table 140. Sun Pharmaceutical Description and Business Overview
Table 141. Sun Pharmaceutical Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. Sun Pharmaceutical Product
Table 143. Sun Pharmaceutical Recent Development
Table 144. Oxford Pharm Corporation Information
Table 145. Oxford Pharm Description and Business Overview
Table 146. Oxford Pharm Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 147. Oxford Pharm Product
Table 148. Oxford Pharm Recent Development
Table 149. Novel Laboratories Corporation Information
Table 150. Novel Laboratories Description and Business Overview
Table 151. Novel Laboratories Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 152. Novel Laboratories Product
Table 153. Novel Laboratories Recent Development
Table 154. Breckenridge Pharmaceutical Corporation Information
Table 155. Breckenridge Pharmaceutical Description and Business Overview
Table 156. Breckenridge Pharmaceutical Methylphenidate Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 157. Breckenridge Pharmaceutical Product
Table 158. Breckenridge Pharmaceutical Recent Development
Table 159. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 160. Key Challenges
Table 161. Market Risks
Table 162. Main Points Interviewed from Key Methylphenidate Drug Players
Table 163. Methylphenidate Drug Customers List
Table 164. Methylphenidate Drug Distributors List
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Methylphenidate Drug Product Picture
Figure 2. Global Methylphenidate Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Tablet Product Picture
Figure 4. Capsule Product Picture
Figure 5. Global Methylphenidate Drug Sales Market Share by Application in 2020 & 2026
Figure 6. Children(6-17 years)
Figure 7. Adult
Figure 8. Methylphenidate Drug Report Years Considered
Figure 9. Global Methylphenidate Drug Market Size 2015-2026 (US$ Million)
Figure 10. Global Methylphenidate Drug Sales 2015-2026 (K Units)
Figure 11. Global Methylphenidate Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Methylphenidate Drug Sales Market Share by Region (2015-2020)
Figure 13. Global Methylphenidate Drug Sales Market Share by Region in 2019
Figure 14. Global Methylphenidate Drug Revenue Market Share by Region (2015-2020)
Figure 15. Global Methylphenidate Drug Revenue Market Share by Region in 2019
Figure 16. Global Methylphenidate Drug Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Methylphenidate Drug Revenue in 2019
Figure 18. Methylphenidate Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Methylphenidate Drug Sales Market Share by Type (2015-2020)
Figure 20. Global Methylphenidate Drug Sales Market Share by Type in 2019
Figure 21. Global Methylphenidate Drug Revenue Market Share by Type (2015-2020)
Figure 22. Global Methylphenidate Drug Revenue Market Share by Type in 2019
Figure 23. Global Methylphenidate Drug Market Share by Price Range (2015-2020)
Figure 24. Global Methylphenidate Drug Sales Market Share by Application (2015-2020)
Figure 25. Global Methylphenidate Drug Sales Market Share by Application in 2019
Figure 26. Global Methylphenidate Drug Revenue Market Share by Application (2015-2020)
Figure 27. Global Methylphenidate Drug Revenue Market Share by Application in 2019
Figure 28. China Methylphenidate Drug Sales Growth Rate 2015-2026 (K Units)
Figure 29. China Methylphenidate Drug Revenue Growth Rate 2015-2026 (US$ Million)
Figure 30. China Methylphenidate Drug Market Share in Global Market 2015-2026
Figure 31. China 5 and 10 Largest Methylphenidate Drug Players Market Share by Revenue in Methylphenidate Drug in 2019
Figure 32. China Methylphenidate Drug Revenue Share by Type (2015-2020)
Figure 33. China Methylphenidate Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 34. China Methylphenidate Drug Revenue Share by Application (2015-2020)
Figure 35. China Methylphenidate Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 36. North America Methylphenidate Drug Sales Growth Rate 2015-2020 (K Units)
Figure 37. North America Methylphenidate Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Methylphenidate Drug Sales Market Share by Country in 2019
Figure 39. North America Methylphenidate Drug Revenue Market Share by Country in 2019
Figure 40. U.S. Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 41. U.S. Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 43. Canada Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Europe Methylphenidate Drug Sales Growth Rate 2015-2020 (K Units)
Figure 45. Europe Methylphenidate Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Methylphenidate Drug Sales Market Share by Country in 2019
Figure 47. Europe Methylphenidate Drug Revenue Market Share by Country in 2019
Figure 48. Germany Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 49. Germany Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 51. France Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.K. Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 55. Italy Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 57. Russia Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Asia Pacific Methylphenidate Drug Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Methylphenidate Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Methylphenidate Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Methylphenidate Drug Revenue Market Share by Region in 2019
Figure 62. China Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Latin America Methylphenidate Drug Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Methylphenidate Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Methylphenidate Drug Sales Market Share by Country in 2019
Figure 87. Latin America Methylphenidate Drug Revenue Market Share by Country in 2019
Figure 88. Mexico Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Middle East and Africa Methylphenidate Drug Sales Growth Rate 2015-2020 (K Units)
Figure 95. Middle East and Africa Methylphenidate Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Methylphenidate Drug Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Methylphenidate Drug Revenue Market Share by Country in 2019
Figure 98. Turkey Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 99. Turkey Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 101. Saudi Arabia Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Methylphenidate Drug Sales Growth Rate (2015-2020) (K Units)
Figure 103. U.A.E Methylphenidate Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Porter's Five Forces Analysis
Figure 105. Methylphenidate Drug Value Chain
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Bottom-up and Top-down Approaches for This Report
Figure 109. Data Triangulation
Figure 110. Key Executives Interviewed